Massachusetts Voters Reject Question 4 to Legalize Psychedelics

Massachusetts voters have rejected Question 4, an initiative that sought to legalize the possession and personal cultivation of small amounts of certain psychedelics, including DMT, psilocybin, psilocin, ibogaine, and non-peyote mescaline.

Psilocybin (top left), mescaline (top right), DMT (bottom left), and psilocin (bottom right).

At the time of publication, votes are still being counted, but based on a detailed examination of election data, The Marijuana Herald is confident in saying that voters will reject Question 4.

The initiative, backed by the nonprofit Massachusetts for Mental Health Options (MMHO), would have allowed adults to possess up to one gram of DMT, one gram of psilocybin, one gram of psilocin, 18 grams of non-peyote mescaline, and 30 grams of ibogaine for personal use. Individuals caught with up to twice these amounts would have faced fines of up to $100.

The measure also proposed establishing licensed service centers under the supervision of a new Natural Psychedelic Substances Commission, modeled after the state’s Cannabis Control Commission, to regulate these substances with a 15% excise tax. The initiative, however, will not take effect following its rejection by voters, leaving Massachusetts’ existing policies on psychedelics unchanged.

Currently, only Colorado and Oregon have legalized psilocybin or any other psychedelic that’s on the federal controlled substances list.

In Massachusetts, six different cities have passed ordinances decriminalizing the possession of psilocybin, the psychedelic compound found in magic mushrooms. Salem was the most recent in May, joining Cambridge, Somerville, Easthampton, Northampton, and Amherst.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Tilray Brands Posts Record $217.5M Q2 Revenue

Tilray Brands Posts Record $217.5M Q2 Revenue

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos